Objectives: Obstetric anal sphincter injuries (OASI) are a major risk factor for fecal incontinence (FI). Neuromodulation is often used as second-line therapy for FI, but evidence for its efficacy is conflicting. We aimed to evaluate the efficacy and predictive factors of posterior tibial nerve stimulation for obstetric anal sphincter injury-induced FI.
INTRODUCTION
Obstetric anal sphincter injury (OASI) is defined as a perineal tear occurring during vaginal delivery, associated with partial or complete rupture of external and/or internal anal sphincters; the reported incidence is up to 11% of vaginal births (1). OASI is a major predisposing factor for, and associated with a significant incidence of, fecal incontinence (FI) in adult women (2) (3) (4) . Although a nonfatal condition, FI has a major impact on quality of life with significant pyschosocial effects among sufferers.
Management of FI begins with conservative measures including dietary advice, stool bulking fiber supplements, constipating drugs, and biofeedback therapy (5, 6) . Neuromodulation is now widely used as a second-line treatment when conservative options fail. Sacral nerve stimulation (SNS) was the first form of neuromodulation to be widely used for FI (7) . Posterior tibial nerve stimulation (PTNS) was subsequently introduced to neuromodulate the sacral nerve plexus remotely, in an attempt to produce the same effects in a simpler, cheaper, safer, and less invasive fashion. The mechanism of action of both SNS and PTNS is, however, unknown; no changes in anorectal physiology are found following neuromodulation, even when there is symptomatic benefit. It is proposed that modulation of central pathways controlling colorectal motility and afferent sensory perception may contribute (5, 8) .
Evidence regarding the efficacy of PTNS for FI is conflicting. Whereas a number of observational studies and a small randomized trial involving a sham arm all demonstrated benefits for PTNS (9, 10) , a recently published large randomized trial found no significant benefit of PTNS over sham stimulation (11) . While differences in methodology and failure to account for placebo effect undoubtedly explain some of the discrepancy, patient selection may also be one potential cause of these conflicting results. Therefore, the aim of the present study is to, through use of a responder analysis, identify factors associated with and potentially predictive of treatment response among a specific cohort of females who underwent PTNS for FI related to OASI.
MATERIAL AND METHODS

Study Design
A retrospective analysis of prospectively collected data was performed. Consecutive females who received PTNS treatment for FI associated with past OASI were included. FI was defined as the accidental or involuntary loss of liquid or solid feces. These subjects were recruited from a single tertiary referral center between 2012 and 2015. They had all failed conservative therapies comprising antidiarrheal drugs, stool bulking agents, and biofeedback as per our Unit protocol (12, 13) . Exclusion criteria included the presence of any other potential cause of FI, whether or not it was the primary etiology or occurring in combination with OASI. Such causes comprised especially patients with neurological conditions (spinal cord injury, multiple sclerosis, Parkinson's disease, and diabetic neuropathy) as well as those with anorectal anatomic abnormalities or previous anal surgery. Females more than 50 years were also excluded given the increased likelihood of other such contributing factors being present. These measures together excluded three subjects, but ensured that the etiology of FI in the included patients was purely obstetric. We also excluded two patients who failed to attend their prescribed PTNS sessions in a regular fashion. This left us with a study population of 37 subjects, all of whom had undergone anorectal physiology testing and endoanal ultrasound prior to PTNS therapy.
Ethics committee approval was not necessary as this was a retrospective analysis of standard practice in the unit.
Posterior Tibial Nerve Stimulation
Patients received PTNS according to a standardized nurseadministered protocol in a similar fashion as has been previously described (10, 14) . A 34-gauge needle was inserted 5 cm cephalad to medial malleolus and 2 cm posterior to tibia at a 60 angle with a base electrode placed on the ipsilateral leg. Therapy was performed with the patient in sitting or supine position. Both electrodes are then connected to the neurostimulator device (Urgent PC, Cogentix, Manchester, UK). Correct needle placement confirmed by motor and/or sensory response (flexion of big toe, fanning of all toes, or tingling sensation of foot extending to all toes). A suitable neurostimulation setting was then chosen whereby the patient was able to comfortably receive 30 min of therapy; subjects received neuromodulation therapy at this optimal setting on a weekly basis for a minimum of 8 weeks. If no response was obtained at 8 weeks then therapy was ceased, given little likelihood of subsequent treatment response; however those who exhibited some response during the first 8 weeks continued therapy so that they completed 12 weeks in total (15) .
Outcomes
Characteristics of study patients at baseline including age, number of vaginal deliveries, and obstetric risk factors for FI were collected. Validated measures of symptom severity in patients with FI were administered both at baseline and immediately following therapy:
• The Wexner Incontinence questionnaire is a validated and reproducible measure for assessing severity of FI; it does so on a scale of 0-20, with 0 representing the absence of any symptoms and 20 corresponding to the greatest severity of symptoms (16).
• The Rockwood score is a validated quality of life measure specific to FI (17) . It assigns a score for each of four domains, lifestyle, coping/behavior, depression/self-perception, and embarrassment. These were scored between 1 and 5, with 1 indicating a lower functional status or quality of life.
• Visual analogue scales (VAS) were used to assess bowel and bladder symptoms. Each VAS was anchored between 0 and 100, with 0 = no problems with function and 100 = worst possible problems with function, a separate scale being used for bowel and bladder function.
• The Bristol Stool Form Scale has not been validated for use specifically in FI, but is a valid and reliable 7-point scale used extensively in clinical and research settings for measurement of stool form in both healthy patients and those with diarrhea (18) . Type 1 stools are excessively hard and dry whereas type 7 are the most watery and types 3 and 4 are normal stools.
All patients were considered as one cohort. Subjects were classified as responders to the treatment administered if they fulfilled the dual criteria of: reduction in Wexner score to below 10, and halving of the baseline score, as has been used on previous occassions (19) (20) (21) . Subjects not fulfilling either criteria were deemed nonresponders. Characteristics of responders and nonresponders were then compared to identify factors potentially predictive of response to therapy.
Statistical Analysis
Data analysis was performed using STATA software. Normally distributed data were expressed as mean and standard deviation, and median and interquartile range (IQR) were measured for nonparametric data. Paired t-tests compared normally distributed data at baseline and conclusion of treatment to determine how PTNS impacted Wexner score, and Mann-Whitney U tests compared nonparametric data. Chi-squared test was used to compare quantitative data. A p-value of <0.05 was considered statistically significant.
RESULTS
Demographics
Thirty-seven female patients fulfilled the criteria and were included in the analysis. Mean age at treatment was 38 (range 24-48) and was similar in responders and nonresponders (p = 0.66). Median parity was 2 (IQR 1-2). Mean time since injury was 5.2 years (range 0.5-9.0). Perineal tear type was fourth degree in 5 patients (14%), third degree in 15 (41%), second degree in 15 (41%), and first degree in 2 (5%). Thirty-two patients (86%) had repair of the perineal tear postdelivery and most of these were primary repairs only (28 primary repair only, 4 secondary repair). A total of 22 patients (69%) had a history of instrumentation during vaginal delivery (17 forceps, 3 Ventouse extraction, and 2 both). Twenty-three patients (62%) had a history of episiotomy and ten subjects (27%) had a history of delivering a baby with a birthweight >4 kg. Seventeen subjects (46%) had ultrasonographically assessed defects of the external anal sphincter with or without an additional internal anal sphincter defect.
Of the total cohort, 14 patients (38%) patients demonstrated a response to treatment assessed by the Wexner score as described above. Mean Wexner score at baseline was 13 in both responders and nonresponders, however this dropped to four in responders posttherapy (p < 0.01 c.f. baseline) whereas there was no significant change in Wexner post therapy in the nonresponders. All patients continued on to the maintenance phase of PTNS therapy.
Obstetric Risk Factors for FI and Treatment Response
Overall, no association was found between the presence or absence of obstetric risk factors for FI and response to PTNS ( Table 1 ). The likelihood of treatment response did not differ between women who had delivered high-birthweight babies, defined as >4 kg, and those who had not (p = 0.87). Similarly, a history of episiotomy (p = 0.84) or of instrumentation during vaginal delivery (p = 0.64) had no bearing on treatment response. The majority of patients (86%) had undergone perineal repair. Those who had secondary repair of obstetric perineal tears had a universally poor treatment response to PTNS (0% responders) but the numbers were small and overall, there was no significant difference found in likelihood of treatment success between those who had primary, secondary vs. no history of repair of an obstetric tear (p = 0.27). There was no correlation between the severity of obstetric perineal tear and the likelihood of response (p = 0.72), though there was a trend toward worse likelihood of response with greater severity of tear (Table 1) .
Association Between Physiological Parameters and Treatment Response
Comparing physiological parameters at baseline between responders and nonresponders, the only differentiating feature was in rectal sensitivity to balloon distension, with significantly lower mean threshold volume (26 AE 9 mL vs. 35 AE 13 mL, p = 0.02) and urge volumes (56 AE 16 mL vs. 72 AE 26 mL, p = 0.03) prior to treatment among responders compared with nonresponders. In contrast, resting, squeeze, and cough pressures, as well as sensitivity of both anus and rectum to electrical stimulation, were similar at baseline between responders and nonresponders ( Table 2) .
Association Between Sphincter Integrity and Treatment Response
Of responders, the majority had ultrasonographically visible defects in integrity of the internal sphincter, external sphincter, or both; in contrast, nonresponders tended to have intact sphincters as visualized by endoanal ultrasound. In fact, 59% of those with defective sphincters responded to PTNS compared to only 20% of those with intact sphincters (p < 0.01).
Association Between Improvement in Wexner Score and Other Outcome Measures
At baseline, responders were in fact more impaired, as assessed by the VAS for bowel symptoms, compared with nonresponders (mean VAS bowel score 63 AE 19 vs. 49 AE 20, p = 0.03); however in terms of the other outcome measures of symptom severity assessed, there were no statistically significant differences.
Following treatment, the greater improvement in Wexner score in responders was associated with corresponding greater improvements in some (but not all) of the other measures of symptom severity when compared with the nonresponders (Table 3) . Significant improvement was noted in the Rockwood score for depression and embarrassment, as well as the mean VAS score for bowel symptoms in responders. No improvement in any of these outcome measures was found among nonresponders.
Responders also exhibited a significant improvement in stool consistency; the median Bristol Stool Form score improved from 5 (IQR = 1) to 3 (IQR = 2) with treatment in responders (p < 0.01) while no significant improvement in stool consistency was noted in nonresponders.
DISCUSSION
We report on the utility of PTNS in patients with FI caused singularly by obstetric injury, identifying a 38% response rate with such neuromodulation. This is the first series to report on this well-defined patient group. Our response rate is lower than that seen in most other case series of PTNS in "all-comers" with FI, where response rates of 63-82% were reported (9). The differences might be due to the careful selection of this patient group, or alternatively because of the methodology used to assess clinical response. Of note, one series with a similar outcome measure as the present study also reported a 38% response rate (22) . A recent study evaluated the efficacy of 3 weeks of PTNS in patients with OASI-related FI, and found that the response rate was far superior among older, postmenopausal patients who were excluded from the present study (23) . We chose to exclude such patients from our study as it is more likely that these patients have other secondary nonobstetric factors contributing to FI, which can be difficult to identify and could therefore compromise the validity of our findings. Another randomized controlled trial of transcutaneous PTNS vs. sham found significant improvement in (24), highlighting the impact that choice of outcome measure can make (25) . We chose reduction in Wexner score rather than a percentage reduction in FI episodes as our primary outcome as it is more holistic, multifaceted, and relevant to the patient (26) . The response to therapy demonstrated did not require sphincter integrity, in fact patients with a disrupted sphincter seemed to do better. This is not necessarily surprising, given that modern hypotheses regarding the mechanism of PTNS emphasize the role of activation of multiple somato-visceral reflexes rather than simple enhancement of anal sphincter activity (27) . However, it is of importance as, to date, the majority of studies exploring the efficacy of PTNS in FI have not reported on sphincter integrity as a predictive factor and often excluded patients with sphincter defects (22, 28, 29) . This finding adds further weight to the argument that patients with sphincter defects should not be precluded from trialing PTNS.
Analyzing the physiological parameters at baseline, there was no factor associated with treatment success other than that responders tended to have slightly greater sensitivity to mechanical stimulus, as measured by a statistically significant lower urge and maximal tolerated volume in this group. Given that rectal hypersensitivity is an important parameter contributing to FI (30) , this finding is noteworthy. It may be that modification of rectal sensitivity is an important mechanism by which neuromodulation improves symptoms, as demonstrated previously by Fassov et al. (31) . However, as the magnitude of difference found in the present study was small, definitive conclusions cannot be drawn; but it merits re-examination in a future larger study, ideally with remeasurement of rectal sensitivity posttherapy also.
While we did not find any statistically significant correlation between any obstetric risk factors and response to PTNS, there was a trend to better response among those who had lesser severity of perineal trauma (50% responders for Grade I tears, 20% responders for Grade IV tears), and in those who had no history of perineal repair vs. those who did, with all secondary repairs being treatment failures (Table 1) . Our study may have been underpowered to detect significant differences between these subgroups, but on the other hand, if this was a true association, it would seem to be incongruous with our other finding that those with disrupted sphincters responded better to PTNS. To our knowledge, only one other study has examined for the presence of such an association and if anything, found that Grade IV tears tended to do better, in contrast to our findings; though again the differences were not statistically significant (23) . Ultimately, a higher powered study is needed before drawing definitive conclusions.
Among those classed as responders, there was a significant improvement in the depression and embarrassment domains of the quality of life score; this is in keeping with the previously demonstrated correlation between Wexner score and quality of life (32) . However, we did not observe corresponding improvements in other quality of life domains of lifestyle and coping. Looking closer at the questionnaire, the reason for this discrepancy is likely due to the quality of life aspects covered in the latter two domains being more multifactorial and less specific to incontinence, for example, questions asking about level of sexual desire (25) . Improvement in the VAS for bowel symptoms, another patient-centric outcome measure, was also observed; this is in keeping with the idea that those that we classified as having demonstrated benefit from PTNS indeed derived a meaningful improvement in symptoms and quality of life from the therapy. The obvious limitation of this study is the absence of a control group. While we acknowledge the potential for high-placebo responses in trials of FI therapies, this study still adds valuable information by circumventing some of the problems with the randomized controlled trials that have been published to date; namely, by assessing efficacy using a more patient-centric outcome measure (Wexner score), and by presenting data on a targeted patient group.
CONCLUSION
In this carefully worked-up cohort of patients with FI purely due to past OASI, we found a 38% response rate following PTNS therapy, as assessed by improvement in Wexner score. Along with improvement in the Wexner score, responders to therapy also demonstrated significant improvements in other global measures of wellbeing including depression and embarrassment quality of life scores, as well as in the VAS for bowel symptoms. The presence of ultrasonographically identified defects in the external and/or internal anal sphincter predicted treatment success.
COMMENTS
The authors present their experience treating sphincter defect related fecal incontinence with tibial stimulation in a young female population with documented abnormalities following obstetrical injury. This study is salient given the documented difference in manometric findings in the group that had results. This can guide clinicians in their decision making regarding which patients might potentially benefit from PTNS. The major caveat to this publication is choice of surgical treatment. In a cohort where half of the patients developed grade 3 or 4 tears of the sphincter and were persistently incontinent following recovery from childbirth, there is no mention of sphincertoplasty as a viable and potentially more effective treatment for the correction of these symptoms. PTNS is less invasive for certain. However, it does not restore the normal anatomy in this area. Perhaps PTNS should be considered as an alternative to permanent sacral modulation for patients with low grade injury.
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